|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Acceleron Pharma, Inc.
| | | Phone: | (617) 649-9200 | Fax: | (617) 649-9988 | Year Established: | 2003 | Main Contact: | John Quisel, CBO | | Other Contacts: | James Desiderio, Ph.D., VP, RA Christopher Rovaldi, VP, Program Management Tracey Sacco, VP, Market Development Ravi Kumar, Ph.D., CSO Kevin McLaughlin, CFO Habib Dable, President & CEO Robert K. Zeldin, M.D., CMO Sujay Kango, CCO
| | Company Description | Acceleron is a privately-held biopharmaceutical company committed to discover, develop, manufacture and commercialize novel protein therapeutics for orphan diseases and cancer. Acceleron’s scientific approach takes advantage of its unique insight to discover first-in-class therapies based on the TGF-? protein superfamily. Acceleron utilizes proven biotherapeutic technologies and capitalizes on the company’s internal GMP manufacturing capability to advance its therapeutic programs rapidly and efficiently. The investors in Acceleron include Advanced Technology Ventures, Alkermes, Avalon Ventures, Bessemer Ventures, Celgene, Flagship Ventures, MPM BioEquities, OrbiMed Advisors, Polaris Ventures, QVT Financial, Sutter Hill Ventures and Venrock. | |
|
|
|
|
|